Clinical Trial Update: Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (RESILIENT) is actively recruiting to evaluate randomization strategies for extending intravenous thrombolysis with tenecteplase in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (TNK-tPA) (tenecteplase)

Snippet

Sponsor: Hospital Moinhos de Vento | Conditions: Ischemic Stroke, Acute | Phase 3 | Status: RECRUITING